VASOCONSTRICTOR RESPONSES TO POLYMORPHONUCLEAR LEUKOCYTES FROM ATHEROSCLEROTIC RABBITS

Citation
Cg. Sobey et al., VASOCONSTRICTOR RESPONSES TO POLYMORPHONUCLEAR LEUKOCYTES FROM ATHEROSCLEROTIC RABBITS, Clinical and experimental pharmacology and physiology, 21(2), 1994, pp. 153-156
Citations number
12
Categorie Soggetti
Pharmacology & Pharmacy",Physiology
ISSN journal
03051870
Volume
21
Issue
2
Year of publication
1994
Pages
153 - 156
Database
ISI
SICI code
0305-1870(1994)21:2<153:VRTPLF>2.0.ZU;2-K
Abstract
1. The vascular contractile effects of polymorphonuclear leucocytes (P MN) isolated from control rabbits and from rabbits made atheroscleroti c by 1% cholesterol feeding for 8 weeks were examined. 2. Rings of con trol rabbit thoracic aorta with or without endothelium were mounted at 2g tension in 10 mL organ baths and were submaximally contracted by p henylephrine (0.1 mu mol/L). After 30 min incubation at 37 degrees C, the supernatant of PMN (5 X 10(7)/mL, in Tyrode solution containing 0. 25% bovine serum albumin) was obtained by centrifugation for addition to the vascular preparation. 3. Control PMN supernatant (443 mu L) cau sed contraction (0.58+/-0.15g, n = 11) of phenylephrine-contracted aor tic rings, which was prevented by removal of the endothelium (0.11+/-0 .07 g, n = 5, P<0.05). However, the control PMN supernatant had no con tractile effect on aortic rings at resting tension (0.00+/-0.00g, n = 8). 4. By comparison, atherosclerotic PMN supernatant (443 mu L) cause d a significantly greater contraction of the aortic rings (1.41+/-0.13 g, n = 9, P<0.05 vs control PMN supernatant) that was only partly inhi bited by removal of the endothelium (0.45+/-0.20g, n = 9, P<0.05). Mor eover, PMN supernatants from four of seven atherosclerotic rabbits con tracted aortic rings at resting tension (3.5+/-1.4g, n = 7). 5. These results suggest that the release of a stable vasoconstrictor substance (s) by PMN is enhanced under conditions of atherosclerosis. The constr ictor action of this substance(s) appears to be greater in the presenc e of a functional endothelium, and part of its action may involve inac tivation of endothelium-derived nitric oxide.